[27- Hydroxycholesterol reverses estradiol induced inhibition of platelet aggregation in postmenopausal women]

Rev Med Chil. 2016 Nov;144(11):1377-1381. doi: 10.4067/S0034-98872016001100002.
[Article in Spanish]

Abstract

Background: The decline of estrogen levels increases cardiovascular risk in women. Platelets express estrogen receptors and 17β-estradiol- (E2) can produce a protective effect on thrombus formation. The hydroxylation of cholesterol generates several sterols and 27-hydroxycholesterol (27HC) predominates in circulation.

Aim: To evaluate the effect of 27HC as an endogenous antagonist of the anti-aggregating properties of E2 in platelets of postmenopausal women.

Material and methods: Platelet function of postmenopausal women was evaluated ex-vivo. Platelets pre-incubated with 27HC in the presence or absence of E2, were stimulated with collagen. Aggregation was evaluated using turbidimetry using a Chrono-log aggregometer.

Results: Collagen-stimulated platelet aggregation was significantly inhibited by E2. The inhibitory effect of E2 on collagen-stimulated platelet aggregation was significantly reversed in the presence of 27HC.

Conclusions: The suppressive effect of E2 on platelet aggregation is inhibited by 27HC, which could contribute to increase cardiovascular risk in postmenopausal women.

MeSH terms

  • Aged
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism
  • Cardiovascular Diseases / etiology
  • Collagen / pharmacology
  • Estradiol / metabolism
  • Estrogen Antagonists / pharmacology*
  • Estrogens / pharmacology*
  • Female
  • Humans
  • Hydroxycholesterols / pharmacology*
  • Middle Aged
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors
  • Postmenopause / blood*
  • Reference Values
  • Risk Factors
  • Statistics, Nonparametric

Substances

  • Estrogen Antagonists
  • Estrogens
  • Hydroxycholesterols
  • Platelet Aggregation Inhibitors
  • Estradiol
  • 27-hydroxycholesterol
  • Collagen